Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Living human lung slices for ex vivo modelling of lung cancer
Siavash Mansouri, Annika Karger, Clemens Ruppert, Marc A. Schneider, Andreas Weigert, Rajender Nandigama, Blerina Aliraj, Lisa Strotmann, Anoop V. Cherian, Diethard Pruefer, Peter Dorfmuller, Ludger Fink, Ibrahim Alkoudmani, Stefan Gattenlöhner, Bastian Eul, Andre Althoff, Peter Kleine, Hauke Winter, Andreas Guenther, Hossein-Ardeschir Ghofrani, Soni S. Pullamsetti, Friedrich Grimminger, Werner Seeger, Rajkumar Savai
Siavash Mansouri, Annika Karger, Clemens Ruppert, Marc A. Schneider, Andreas Weigert, Rajender Nandigama, Blerina Aliraj, Lisa Strotmann, Anoop V. Cherian, Diethard Pruefer, Peter Dorfmuller, Ludger Fink, Ibrahim Alkoudmani, Stefan Gattenlöhner, Bastian Eul, Andre Althoff, Peter Kleine, Hauke Winter, Andreas Guenther, Hossein-Ardeschir Ghofrani, Soni S. Pullamsetti, Friedrich Grimminger, Werner Seeger, Rajkumar Savai
View: Text | PDF
Research Article Immunology Oncology

Living human lung slices for ex vivo modelling of lung cancer

  • Text
  • PDF
Abstract

The tumor microenvironment (TME) markedly affects cancer progression, yet traditional animal models do not fully recapitulate the situation in humans. To address this, we developed tumor-derived precision lung slices (TD-PCLS), an ex vivo platform for studying the lung TME and evaluating therapies. TD-PCLS, viable for 8–10 days, preserve the heterogeneity and metabolic activity of primary tumors, as confirmed by seahorse analysis. Using multispectral FACS and phenocycler multiplex imaging, we spatially profiled TME components and cancer cell functionality. Additionally, TD-PCLS revealed patient-specific responses to chemo- and immunotherapies. To complement TD-PCLS, we established tumor-cell–seeded PCLS (TCS-PCLS) by introducing tumor and immune cells into healthy lung slices. This model highlighted macrophage-tumor interactions as critical for tumor cell proliferation, migration, and immune modulation. Together, these platforms provide a robust tool for lung cancer research, enabling precision medicine and advancing therapeutic discovery.

Authors

Siavash Mansouri, Annika Karger, Clemens Ruppert, Marc A. Schneider, Andreas Weigert, Rajender Nandigama, Blerina Aliraj, Lisa Strotmann, Anoop V. Cherian, Diethard Pruefer, Peter Dorfmuller, Ludger Fink, Ibrahim Alkoudmani, Stefan Gattenlöhner, Bastian Eul, Andre Althoff, Peter Kleine, Hauke Winter, Andreas Guenther, Hossein-Ardeschir Ghofrani, Soni S. Pullamsetti, Friedrich Grimminger, Werner Seeger, Rajkumar Savai

×

Figure 6

Preparation and applications of TCS-PCLS.

Options: View larger image (or click on image) Download as PowerPoint
Preparation and applications of TCS-PCLS.
(A) Workflow of preparation of...
(A) Workflow of preparation of TCS-PCLS by implementation of A549-positive GFP on nontumor/healthy PCLS. Created in Biorender.com. (B) Healthy PCLS was seeded with A549-GFP cells. After 24 hours, tissue was fixed and imaged with the Leica Thunder Imager using the lung autofluorescence (red), and the GFP signal emitted from A549 cells (green). Scale bar: 500 μm (right), 100 μm (left, magnification). (C) Healthy PCLS was cultured with A549-GFP spheroids for 24 hours. Spheroid outgrowth was imaged with the Leica SP8 confocal microscope using the Lung autofluorescence (red) and the GFP signal (green). Scale bar: 250 μm. (D) Healthy PCLS was seeded with A549-GFP cells. Time lapse imaging was done with the Keyence New All-in-One Fluorescence Microscope BZ-X800 in a stage top incubator for 24 hours. Scale bar: 500μm. (E) Healthy PCLS was seeded with A549-GFP cells and cultured for 24 hours. Prior fixation, 20 μM EdU was added overnight and visualized using the Click-iT EdU Kit. Slices were imaged using the Leica SP8 confocal microscope for the Lung autofluorescence (red), GFP signal (green), and EdU incorporation (magenta). Scale bar: 100 μm. (F) Healthy PCLS was seeded with A549-GFP and then cultured in different types of macrophage-conditioned medium (CM) for 24 hours, including naive unstimulated M0 macrophages, tumor-promoting M2 macrophages (stimulated with IL4 for 24 hours), antitumor M1 macrophages (stimulated with LPS and IFN-γ for 24 hours). Slices were imaged using the Leica SP8 confocal microscope. Scale bar: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts